Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadratus lumborum nerve block in laparoscopic myomectomy
NCT03935815Phase 1Terminated
- Sponsor
- University of California, Los Angeles
- Start
- May 2019
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ropivacaine in postoperative pain, sponsored by University of California, Los Angeles. Primary endpoint: Morphine equivalents consumption at 24 hours. Started May 2019; status: terminated.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03935815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03935815.